Your Skin Produces Natural Antibiotic Peptides in Response to Bacterial Colonization | Research

The takeaway

The skin produces a diverse array of antimicrobial peptides both constantly and in response to microbial colonization, with different peptides targeting different bacterial and fungal species.

Both constitutive and inducible AMP defense
The skin maintains always-on antimicrobial peptides plus additional peptides activated by specific microbial threats

What the researchers found

The skin expresses antimicrobial peptides both constitutively (always on) and in response to pathogenic microbial stimuli. These AMPs are differentially effective against various bacterial and fungal skin colonizers — meaning different peptides target different microbes.

Commensal bacterial colonization of the skin is vital for training and maintaining both innate and adaptive immune functions. The skin's AMP defense works alongside its physical barrier to prevent pathogen colonization. The review identifies a gap between descriptive disease-state studies and single-species in vitro experiments, calling for research that better mimics natural skin conditions.

Why it matters

Understanding the skin's natural antimicrobial peptide defenses is essential for developing treatments for skin infections, eczema, acne, and other dermatological conditions where the microbe-host balance is disrupted. Rather than relying solely on antibiotics, future therapies could harness or boost the skin's own peptide defenses to restore healthy microbial balance.

How the study worked

This is a literature review that compiled and analyzed published studies on cutaneous antimicrobial peptide expression in response to microbial colonization. The review covers both in vitro studies of individual AMPs against specific microbes and descriptive studies of AMP expression in various skin conditions.

What this study cannot tell us

As a narrative review, findings depend on the quality and scope of underlying studies. Most AMP studies use simplified in vitro conditions (single bacterial species) that don't reflect the complex, multi-species environment of real skin. Direct clinical trial data on therapeutic AMP use for skin conditions is limited. The review was published in 2017, before many recent advances in skin microbiome characterization.

How to read the evidence

This is a narrative review published in Frontiers in Immunology that synthesizes existing research on skin antimicrobial peptide expression. While it provides a valuable overview, it does not include new experimental data or systematic analysis. The underlying evidence is largely from in vitro and descriptive studies.

When this study was published

Published in 2017, this review predates significant advances in skin microbiome research and therapeutic AMP development. More recent studies may have addressed some of the research gaps identified here.

The bigger picture

The explosion in skin microbiome research has revealed that healthy skin depends on a delicate balance between commensal bacteria and the host's immune defenses. Antimicrobial peptides are key mediators of this balance. Understanding how they respond to different microbes could enable personalized approaches to skin health — from probiotic skincare to AMP-based topical treatments for conditions like atopic dermatitis where this balance is disrupted.

Questions still open

Could topical application of specific antimicrobial peptides treat skin conditions caused by microbial imbalance?
How do differences in individual skin AMP expression contribute to susceptibility to conditions like eczema or acne?
Can the skin microbiome be deliberately manipulated to enhance natural AMP production?

Common questions

Does your skin really make its own antibiotics?

Yes — your skin produces a variety of antimicrobial peptides that function as natural antibiotics. Some are always present on the skin surface, while others are produced specifically when harmful bacteria or fungi are detected. These peptides are a key part of your body's first line of defense against skin infections.

Could problems with antimicrobial peptides cause skin conditions like eczema?

Research suggests that people with conditions like atopic dermatitis (eczema) often have altered antimicrobial peptide expression, which may contribute to the bacterial imbalance seen on affected skin. Understanding these connections could lead to new treatments that restore the skin's natural peptide defenses rather than just treating symptoms with steroids or antibiotics.

Read the original research

Endogenous Antimicrobial Peptide Expression in Response to Bacterial Epidermal Colonization.

Frontiers in immunology, 8, 1637

View on PubMed ↗Publisher’s paper ↗

Citation

Brandwein, Michael; Bentwich, Zvi; Steinberg, Doron. (2017). Endogenous Antimicrobial Peptide Expression in Response to Bacterial Epidermal Colonization.. Frontiers in immunology, 8, 1637. https://doi.org/10.3389/fimmu.2017.01637